Foamix Pharmaceuticals Ltd. Common Stock, Par or Stated Value Per Share
Foamix Pharmaceuticals Ltd. had Common Stock, Par or Stated Value Per Share of 0.16 ILS/shares as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockParOrStatedValuePerShare · last filed 2020-03-12
- 2019-12-31: Common Stock, Par or Stated Value Per Share 0.16 ILS/shares.
- 2019-09-30: Common Stock, Par or Stated Value Per Share 0.16 ILS/shares.
- 2019-06-30: Common Stock, Par or Stated Value Per Share 0.16 ILS/shares.
- 2019-04-10: Common Stock, Par or Stated Value Per Share 0.16 ILS/shares.
| Period end | Common Stock, Par or Stated Value Per Share |
|---|---|
| 2019-12-31 | 0.16 ILS/shares 10-K · filed 2020-03-12 |
| 2019-09-30 | 0.16 ILS/shares 10-Q · filed 2019-11-12 |
| 2019-06-30 | 0.16 ILS/shares 10-Q · filed 2019-08-07 |
| 2019-04-10 | 0.16 ILS/shares 10-Q · filed 2019-11-12 |
| 2019-03-31 | 0.16 ILS/shares 10-Q · filed 2019-05-07 |
| 2018-12-31 | 0.16 ILS/shares 10-K · filed 2020-03-12 |
| 2018-09-30 | 0.16 ILS/shares 10-Q · filed 2018-11-07 |
| 2018-06-30 | 0.16 ILS/shares 10-Q · filed 2018-08-08 |
| 2018-03-31 | 0.16 ILS/shares 10-Q · filed 2018-05-08 |
| 2017-12-31 | 0.16 ILS/shares 10-K · filed 2019-02-28 |
| 2017-06-30 | 0.16 ILS/shares 6-K · filed 2017-08-08 |
| 2016-12-31 | 0.16 ILS/shares 10-K · filed 2018-03-01 |
| 2016-06-30 | 0.16 ILS/shares 6-K · filed 2016-08-10 |
| 2015-12-31 | 0.16 ILS/shares 20-F · filed 2017-02-21 |
| 2015-06-30 | 0.16 ILS/shares 6-K · filed 2015-10-19 |
| 2014-12-31 | 0.16 ILS/shares 20-F · filed 2016-03-02 |
| 2014-08-22 | 0.16 ILS/shares 20-F · filed 2015-03-17 |
| 2014-08-21 | 0.01 ILS/shares 20-F · filed 2015-03-17 |
| 2013-12-31 | 0.16 ILS/shares 20-F · filed 2015-03-17 |